Otsuka Pharmaceutical Development & Commercialization, Inc.

1. Grants

   $4.0M

   100%

1. Department of Health and Human Services

   $4.0M

   ›

1. Drug Use and Addiction Research Programs

   $4.0M

   ›

1. Brexpiprazole as an Adjunctive Treatment to Buprenorphine to Treat Opioid Use Disorder

   Dec 15, 2022$4.0M

   ›

1. National Institute of Neurological Disorders and Stroke, National Institutes of Health, Health and Human Services

   075-0886

   $4.0M

   1 awards

Committed to this recipient

The dollars agencies committed to them — signed contracts and awarded grants — counted in the year each action happened.

Lifetime vs. a single year

The profile sections cover the recipient's full history on record; the headline total and the flow bar reflect the fiscal year picked at the top.

“Active in FY X”

A fiscal-year award list shows every award with at least one action that year, at its full lifetime value — a different lens from the by-year chart, which splits each award across the years it was committed.

Names come raw

Recipient names appear exactly as filed, and the government doesn't standardize them, so one organization can show up under a few spelling variants — worth checking near-duplicates before sizing one up.

The colored bars

Every bar on this page splits by how the money moves:

Direct payments

This recipient on USAspending.gov ↗